Drug Shortage Report for SYLVANT
| Report ID | 252358 |
| Drug Identification Number | 02435136 |
| Brand name | SYLVANT |
| Common or Proper name | SYLVANT |
| Company Name | RECORDATI RARE DISEASES CANADA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | SILTUXIMAB |
| Strength(s) | 400MG |
| Dosage form(s) | POWDER FOR SOLUTION |
| Route of administration | INTRAVENOUS INTRAVENOUS |
| Packaging size | 1 X 30 ML vial |
| ATC code | L04AC |
| ATC description | IMMUNOSUPPRESSANTS |
| Reason for shortage | Requirements related to complying with good manufacturing practices. |
| Anticipated start date | |
| Actual start date | 2025-03-06 |
| Estimated end date | 2025-03-31 |
| Actual end date | 2025-03-27 |
| Shortage status | Resolved |
| Updated date | 2025-03-28 |
| Company comments | 100 mg/vial strength is available for distribution and can be used in place of the 400 mg/vial until the stock is available. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 3080 YONGE STREET, SUITE 6060 TORONTO, ONTARIO CANADA M4N 3N1 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v4 | 2025-03-28 | English | Compare |
| v3 | 2025-03-27 | English | Compare |
| v2 | 2025-03-11 | French | Compare |
| v1 | 2025-03-11 | English | Compare |
Showing 1 to 4 of 4